Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 2'-O-Methylguanosine | 2140-71-8 | 99.8% | 297.27 | 250 MG
SDP

Catalog No. 5000451409
Encompass_Preferred

2'-O-Methylguanosine is a modified nucleoside produced in tRNAs by the action of tRNA guanosine-2'-O-methyltransferase. It results in apoptotic changes of cells. For research use only; not sold to patients.

  • Modified nucleoside produced in tRNAs
  • Induces apoptotic changes in cells
  • Can be isolated from the culture supernatant of CD57⁺HLA-DRbright natural suppressor cell (57.DR-NS)
  • Induces apoptosis in Molt4 cells at 7 μg/mL for 72 h
  • Inhibits the activity of RNA-dependent RNA polymerase after nucleotide incorporation by hindering translocation
  • Protects coronavirus RNA from degradation by host nucleases

Catalog No. 50-004-51409 Supplier Medchemexpress LLC Supplier No. 250MGHYW013260
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

2'-O-Methylguanosine is a modified nucleoside produced in tRNAs by the action of tRNA guanosine-2'-O-methyltransferase. It results in apoptotic changes of cells. For research use only; not sold to patients.

  • Modified nucleoside produced in tRNAs
  • Induces apoptotic changes in cells
  • Can be isolated from the culture supernatant of CD57⁺HLA-DRbright natural suppressor cell (57.DR-NS)
  • Induces apoptosis in Molt4 cells at 7 μg/mL for 72 h
  • Inhibits the activity of RNA-dependent RNA polymerase after nucleotide incorporation by hindering translocation
  • Protects coronavirus RNA from degradation by host nucleases

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.